Literature DB >> 10846802

Influence of alpha-escin on skeletal changes in ovariectomized rats.

M Pytlik1, U Cegieła, W Janiec.   

Abstract

The aim of the present study is to investigate the influence of alpha-escin (35 mg/kg per os daily; administered for 4 weeks) on the development of osteopenia caused by bilateral ovariectomy in 3-month-old female Wistar rats. The experiments were carried out on four groups of animals: I (C)--control sham operated rats, II (OVX)--ovariectomized rats, III (E)--sham operated rats which were administered alpha-escin, IV (OVX + E)--ovariectomized rats which were given alpha-escin. In all groups body weight growth, masses, length and tibia diameter were determined as well as histological specimens of right femur and tibia slices were used for histometric measurements including: the transverse cross-section area of the tibial shaft cortex, transverse cross-section area of the tibial marrow cavity, periosteal osteoid width, endosteal osteoid width, periosteal thickness growth in the tibia, endosteal thickness growth in the tibia, epiphyseal and metaphyseal trabeculae thickness in the femur and epiphyseal cartilage width. Bilateral ovariectomy in matured female rats caused osteopenic skeletal changes. alpha-Escin (35 mg/kg per os daily) administered to the ovariectomized rats for the following 28 days decreased only a little the development of osteopenic skeletal changes caused by bilateral ovariectomy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846802

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  1 in total

1.  Escin, a pentacyclic triterpene, chemosensitizes human tumor cells through inhibition of nuclear factor-kappaB signaling pathway.

Authors:  Kuzhuvelil B Harikumar; Bokyung Sung; Manoj K Pandey; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2010-01-26       Impact factor: 4.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.